GE HealthCare Technologies Inc. GEHC
66.63
0.25
0.38%
as of 25 Sep
- Market cap
- $29.9B
- P/E
- 15.3×
Follow GEHC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
GE HealthCare Technologies Inc. (GEHC) Return on equity
GE HealthCare Technologies Inc.'s return on equity over the twelve months to 30 June 2026 was 19.2%, down 3.0 percentage points from fiscal 2025 (22.1%). Over the past ten years it has ranged from 0.00% (fiscal 2020) to 25.5% (fiscal 2024); the current reading is higher than 86% of that period. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 22.1% | (3.43) |
| FY2024 | 25.5% | 8.76 |
| FY2023 | 16.8% | 2.06 |
| FY2022 | 14.7% | 0.42 |
| FY2021 | 14.3% | 14.30 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | — |
Against its own ten years
Low 0.00%
High 25.5%
Ten-year median
14.7%
Current reading's percentile
86
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. | 19.2% |
| BSX Boston Scientific Corporation compare | 15.4% |
| PEN Penumbra, Inc. compare | 11.4% |
| STE STERIS plc compare | 11.4% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| EW Edwards Lifesciences Corporation compare | 9.42% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.41% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on GEHC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement